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Lymphoid Tumors of Xenopus laevis with Different
Capacities for Growth in Larvae and Adults
JACQUES ROBERT,t CHANTAL GUIET,t and LOUIS DU PASQUIER
Basel Institute for Immunology, Postfach, CH-4005 Basel, Switzerland
Three new lymphoid tumors offering an assortment of variants in terms of MHC class
expressions, MHC class II expression, and Ig gene transcription have been discovered in the
amphibian Xenopus. One was developed in an individual of the isogenic LG15 clone
(LG15/0), one in a frog of the LG15/40 clone (derived from a small egg recombinant of
LG15), and one (if-2) in a male ff sib of the individual in which MAR1, the first lymphoid
tumor in Xenopus was found 2 years ago. These tumors developed primarily as thymus
outgrowths and were transplantable in histocompatible tadpoles but not in nonhistocom-
patible hosts. Whereas LG15/0 and LG15/40 tumor cells also grow in adult LG15 frogs, the
if-2 tumor, like the MAR1 cell line, is rejected by adult ff animals. Using flow cytometry with
fluorescence-labeled antibodies and immunoprecipitation analysis, we could demonstrate
that, like MAR1, these three new tumors express on their cell surface lymphopoietic
markers recognized by mAbs FIF6 and RC47, as well as T-cell lineage markers recognized
by mAbs AM22 (CD8-1ike) and X21.2, but not by immunologobulin (Ig) nor MHC class II
molecules. Another lymphocyte-specific marker AM15 is expressed by 15/0 and 15/40 but
not if-2 tumor cells. The if-2 tumor cell expresses MHC class molecule in association with
]2-microglobulin on the surface, 15/40 cells contain cytoplasmic class o chain that is
barely detected at the cell surface by fluocytometry, and 15/0 cells do not synthesize class
o chain at all. The three new tumors all produce large amounts of IgM mRNA of two
different sizes but no Ig protein on the membrane nor in the cytoplasm. All tumor cell types
synthesize large amount of Myc mRNA and MHC class I-like transcripts considered to be
non classical.
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INTRODUCTION
The embryonic and larval development of the
anuran amphibian Xenopus is a good system for
studying ontogenic aspects of the immune system
(review in Flajnik et al., 1987; Du Pasquier et al.,
1989). Moreover, the unique developmental transi-
tion occurring during metamorphosis allows one to
study the regulation of the immune fuction in a way
that is not possible in mammals. During this crisis
period, the immune system undergoes a major
remodeling: MHC class I antigens appear on cell
membranes (Du Pasquier et al., 1979; Flajnik et al.,
1986; Flajnik and Du Pasquier, 1988); the tissue
distribution of MHC class II changes (Du Pasquier
and Flajnik, 1990); the adfflt antibody repertoire
replaces the larval one (review in Du Pasquier et al.,
*Corresponding author.
1989); and an active tolerance to newly arising,
adult-specific antigens is acquired (Du Pasquier and
Bernard, 1980). However, the advantages of this
model have been counterbalanced by a limited
armamentarium of methods for studying the phe-
nomena associated with the metamorphosis of the
Xenopus immune system. This area of research
would greatly benefit from the development of new
models such as cell lines and clones with larval or
adult phenotypes and exhibiting stage-specific re-
sponses in vitro. Lymphoid cell lines are exceedingly
rare in amphibians. In fact only one such line has
been described so far; B3B7 is derived from a thymic
lymphoid tumor MAR1 and grows in histocompat-
ible ff tadpoles but not in histocompatible ff adults
(Du Pasquier and Robert, 1992). Recently, three
new, apparently similar tumors developed in our
colony, each in a different strain. We report here
our characterization of these tumors by in vivo
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transplantation experiments, flow cytometry, immu-
noprecipitation, and Western and Northern blot
analysis. In future experiments on the metamorpho-
sis of the immune system, we hope to be able to
exploit the differences between adult and larval
behavior that we found.
RESULTS
Origin of Lymphoid Tumors
The three new lymphoid tumors were found in our
frog colony during August and September 1992.
They developed primarily in the thymus, and the
frogs bearing a large outgrowth on one side of the
head were easily detected. In each case, samples of
the tumors’ tissue and cell suspension were frozen,
transplanted in other animals, and put into culture
medium in an attempt to grow the cell in vitro.
Transplantation Studies
The if-2 tumor appeared in a male if, sib of the frog
in which the first lymphoid tumor, MAR1, was
detected in December 1991 (Du Pasquier and
Robert, 1992). The animal carrying this tumor was
kept alive as long as possible, and at the time of
sacrifice, two months later, there were multiple
metastases in liver, kidney, spleen, and blood. The
contralateral thymic lobe was not affected by the
tumor. Cells of this tumor are transplantable in
partially inbred MHC-homozygous tadpoles but not
in unrelated larval hosts (Table 1). Ascites contain-
ing about 107 tumor cells are usually obtained 2-3
weeks after intraperitoneal injection of a 5 x 104-
1 x 105 single tumor cell suspension. Like MAR1
cells, if-2 cells are rejected by postmetamorphic
young or fully grown adults of the same family.
Dorsal subcutaneous injections of 1 x 106 cells,
which in our experience is the most sensitive route
of injection in adults, failed to produce any tumor.
Rejection occurs as soon as 1 month after the
completion of metamorphosis. Both in normal and
sodium perchlorate blocked tadpoles (that do not
metamorphose), metastases developed secondarily
in spleen, liver, and at the site of injection. In one
case, metastases were also observed in kidney.
The other two tumors appeared in two LG15
lines--one in the original LG15/40, a clone derived
from a LG15 small egg recombined clone. Both 15/0
and 15/40 tumor cells are transplantable in isogenic
TABLE
Results of Transplantation Experiments with the Different Tumor Cell Types
Tumor Cell Injection Recipient Stage No. of
no. x 106) route MHC animals
Result
if-2
15/40
15/0
0.5 i.p. f/f Tadpole 100
(st. 56-58)
0.5 i.p. f/f Blocked > 100
tadpole
1.0 s.c. f/f 4-year-old 4
adult
0.5 i.p. a/c Tadpole 5
(LG15) (st. 56-58)
0.5 i.p.
0.5 i.p.
1.0 s.c.
1.0 i.p.
0.5 i.p.
0.5 i.p.
0.5 i.p.
2.0 s.c.
0.5 i.p.
a/c Tadpole 50
(LG15) (st. 56-58)
a/c Blocked 50
(LG15) tadpole
a/c 4-year-old 10
(LG15) adult
a/c 4-year-old 5
(LG15) adult LG15
f/f Blocked 10
a/c Tadpole 20
(LG15) (st. 56-58)
a/c Blocked 20
(LG15) tadpole
a/c 4-year-old 7
(LG15) adult
f/f Blocked 10
Ascites, metastasis
Ascites, metastasis
No growth
No growth
Ascites, metastasis
Ascites, metastasis
Subcutaneous tumor at
site of injection, metastasis
Ascites, metastasis
No growth
Ascites, metastasis
Ascites, metastasis
Subcutaneous tumor at
site of injection, metastasis
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LG15 tadpoles but not in allogenic hosts (Table 1).
Three weeks after intraperitoneal injection, tumor
cells were detected as ascites and in metastases.
However, the 15/0 and 15/40 tumor cells differ
strikingly from MAR1 and if-2 in that they also
grow well in 4-year-old LG15 adults. Dorsal subcu-
taneous injections of 2 x 106 cells produce a large
solid tumor containing more than 109 cells after one
month, usually in the space beneath the muscles
and skin at the site of injection. Metastases devel-
oped secondarily in spleen, liver, and kidney. The
15/40 tumor cells transplanted intraperitoneally
also grow albeit at a somewhat slower rate, and after
2 months, ascites and metastases in the spleen were
found. Allogenic adults rejected cells from both
tumors.
In order to check for the presence of infectious
tumor viruses, sonicated supernatants of 15/40 and
MAR1 tumor cells were injected after filtration
through 22-#m membranes into histocompatible
larval and adult hosts. Injected tadpoles metamor-
phosed normally, and even after 1 year, no detect-
able tumors developed. The 15/40 tumor has been
adapted in vitro with essentially the same protocol
as the one described for MAR1 (Du Pasquier and
Robert, 1992).
Characterization of the Cell Surface by Flow
Cytometry
The expression of cell-surface antigens was investi-
gated by flow cytometry after staining with
fluorescence-labeled monoclonal antibodies. Table 2
summarizes the results. Some common features are
shared by all tumor cell types; all of them, like the
previously described MAR1 cell line, are strongly
stained for T-cell markers recognized by mAb AM22
(which is specific for a putative CD8 equivalent of
Xenopus) and X21.2, as well as for the markers of
the lymphopoietic lineage recognized by FIF6 and
RC47. None of the MHC class II-specific mAbs, nor
Ig-specific mAbs, including anti-/, anti-v, anti-z,
anti-Ig light chain, and anti-VH, stain the cell surface
of 15/0 and if-2 tumors. However, MHC class
II-specific mAbs stained 15/40 very weakly; it is not
yet clear whether this represents nonspecific stain-
ing or a very weak expression of MHC class II
molecules. All the Ig-specific mAbs are negative
with the 15/40 tumor cells.
Other features discriminate among the tumors.
The class I-specific TB17 mAb positively stains if-2
cells (Fig. 1); because all live cells are stained, this is
not the result of contamination from host cells. In
TABLE 2
Flow Cytometry Analysis of the Different Tumor Cell Types
Monoclonal antibodies Specificity
Adult lymphocytes
References Spleen Thymus
Tumor cells
B3B7 if-2 15/0 15/40
Anti-MHC TB17 Class (44-45 kd)
AM20 Class II (30 kd)
14A2 Class II (30 kd)
Anti-T cell AM22 CD8-1ike (35 kd)
X21.2 T cell (110 kd)
AM15 T cell popul. (18 kd)
Anti-leucocytes FIF6 leucocyte, erythrocyte
RC47 leucocyte
Anti-Ig 10A9 IgM (60-62 kd)
11D5 IgY (64 kd)
410D9 IgX (66 kd)
13B2 IgL1 (25 kd)
1E9 IgL2 (29 kd)
409B8 IgL3 (27 kd)
10C10 IgVHa
14B4 IgVHb
14D5 IgVHc
aReferences:
1. Hsu and Du Pasquier, 1984
2. Hsu and Du Pasquier, unpublished
3. Hsu et al., 1991
4. Flajnik et al., 1991
5. Flajnik et al., 1990
6. Du Plasquier and Flajnik, 1991
7. Nagata, 1985
8. Flajnik et al., 1988
and relate to the relative brightness of the whole tumor cell population.
ND not done.
4 + +
b (> 90%)
5 + + (> 90%)
5 + + (> 90%)
6 + + (30-50%)
7 + (10-30%)
5 + (75-80%)
8 + (80-90%)
6 ND
+ + (15-30%)
1 + (0.5-1%)
2 + (0.5-2%)
3 + + (2-8%)
3 + (5-10%)
2 + + (5-20%)
+ + (7-30%)
+ + (5-10%)
+ + (2-10%)
+ + (> 95%) +
+ + (> 90%) +
+ + (> 90%) +
+ + (>50-70%) + + + + + + + +
+ (90-95%) + + + +
+ (> 90%) + + +
+ (> 90%) + + + + + + +
+ (> 90%) + +ND + +
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ND
ND
ND
ND
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ND300 J. ROBERT et al.
Neg.
control
AM22
(CD8)
X21,2
oTcell
AM 15
a Lympho
TB17
aclass
Spleen B3B7
leucocytes cell line ff-2 1510 15/40
=,,, ,,=’=
,,i,=
Fluorescence intensity
FIGURE 1. Flow cytometry analysis of normal spleen lymphocytes and the various tumors. The specificity of the monoclonal
antobodies is given in Table 2.
the case of 15/40 tumor cells, there is a slight shift of
the peak with the TB17 mAb that could indicate a
low expression of class molecules at the cell surface
(see Western Blot Analysis). The cells from the other
tumors are not stained by TB17. Another antibody
(AM 15), which stains a lymphocyte subset (Flajnik
et al., 1990) more intensively, stains only 15/40 and
15/0 tumor cells, the latter more intensely. The flow
cytometric profile obtained with normal spleen cells
is usually bimodal with this antibody. The peak
stained most intensely is thought to correspond to T
cells, because it disappears after thymectomy (J. D.
Horton, personal communication). The relative in-
tensity of staining with the general leukocyte marker
FIF6 is significantly less with 15/40 cells than with
normal lymphocytes or B3B7 cells (data not shown).
Comparable profiles of each tumor type were ob-
tained several times, both with samples of the orig-
inal tumor and with transplanted tumor cells. The
surface expression profile of 15/40 tumor cells was
conserved after culture in vitro.
Characterization of the Cell Surface by
Immunoprecipitation
In order to confirm the analysis by flow cytometry,
we used immunoprecipitation after cell-surface io-
dination (Fig. 2). From lysates of all tumor cell types,
including the B3B7 cell line, a unique band, which
corresponds to a band of 36 kd in normal splenocyte
lysates, was detected with mAb AM22 on SDS-
PAGE gels under reducing conditions (Fig. 2B). A
second band of 38 kd, usually present in normal
spleen lysates (Fig. 2A), could not be found even
when the cells were preincubated with the mAb
before lysis (data not shown); this result suggests
that these tumor cells express only one chain of the
putative. CD8 molecule.
With the other T-cell-specific marker recognized
by mAb X21.2, the situation is more complex (Fig.
2B). Whereas three bands are immunoprecipitated
from the B3B7 cell line, only two bands are present
in lysates of if-2, and no signal at all could beLYMPHOID TUMORS OF XENOPUS LAEVIS 301
FIGURE 2. Comparative immunoprecipitation analysis under reducing conditions of cell-surface markers expressed by normal
lymphocytes and the various tumors. (A and B) Surface iodinated lysate from normal outbred lymphocytes and each tumor cell type
were immunoprecipitated by the SPIT technique and separated on 10% SDS-PAGE gels. Lane 1: Negative control with nonspecific
mAb supernatants, Lane 2:TB17 anti-MHC class I, Lane 3:AM22 anti-CD8-1ike, Lane 4:X21.1 anti-T cell. Only one band is present
in 15/0 lysate. (C) Normal lymphocytes and if-2 tumor cells biosynthetically labeled with 35S-methionine were preincubated with (1)
normal nonimmune Xenopus serum or (2) specific anti-ff alloserum, lysed, immunoprecipitated by protein A, and loaded on a 7.5-15%
SDS-PAGE gel gradient.
detected with lysates of 15/40 and 15/0 tumor cells,
even when more gentle washing conditions are
used, and despite the fact that a signal was recorded
in immunofluorescence. Normal spleen lympho-
cytes express one major band, but two faint bands
were also detected after a long exposure (Fig. 2A).
Using the class-I-specific mAb TB17, we precipi-
tated a strong band of 45 kd corresponding to a class
I c chain from cell-surface iodinated if-2 but not the
other tumors. As previously reported, ]/2-micro-
globulin (the MHC class light chain) could not be
detected using this mAb (Flajnik et al., 1991). When
we used a specific anti-ff alloserum preadsorbed be-
fore lysis and immunoprecipitation on metabolically
labeled if-2 tumor cells or normal splenocytes, a band
of 13 kd corresponding to ,82m was clearly seen; this
band was not present in controls with nonimmune
Xenopus serum (Fig. 2C). A higher background is
allways obtained after immunoprecipitation of tu-
mor cell lysates with protein A, even after preincu-
bation with normal Xenopus serum and protein A.
No Ig molecules were detected from iodinated
cell-surface protein of any tumor cell (data not
shown).
Western Blotting
When cell lysates were analyzed by Western blot-
ting, we could identify the MHC class I c chain
protein in lysates of the 15/40 tumor (Fig. 3). To
avoid contamination with host class I, lysates were
prepared from tumor cells grown in vitro. A band
with a slightly slower mobility than that of if-2
tumor cells was clearly present, and no signal was
detected in lysates of 15/0 tumor cells or B3B7. This
difference in gel mobility is probably due to allelic
differences between the LG15 and ff strains of
Xenopus (Flajnik et al., 1991). The integrity of cell
lysates was controlled with mAb AM22, which
stained a band of the expected apparent molecular
weight in all tumor samples, but not in spleen. We
interpret these findings to mean that MHC class c
chain is present at least in the cytoplasm of 15/40
tumor cells.
No Ig could be detected by this Western blotting.
Additional experiments to check for the presence of
IgM in the cytoplasm by metabolic labeling and by
immunofluorescence microscopy on fixed tumor
cells were all negative (data not shown).302 J. ROBERT et al.
FIGURE 3. Western blot analysis by chemoluminescence assays
of CD8-1ike and MHC class molecules under reducing condi-
tions from normal spleen lymphocytes and each tumor cell type.
Northern Blotting
Although cells of the three new tumors do not
express Ig molecules on the cell surface or in the
cytoplasm, they all produce large amounts of /
heavy-chain mRNA detectable on Northern blots;
no signal at all could be detected in the B3B7 cell
line (Fig. 4). In all three new tumors, the C/ probe
detects, in addition to the usual 1.8-kb / mRNA
previously described (Schwager et al., 1988), an-
other transcript of 1.35 kb that is barely detectable
in normal lymphocytes. The shorter / band was
observed in several experiments, and it does not
seem to result from a general RNA degradation, as
judged by hybridization of other probes on the same
membrane. The large amount of specific/ messen-
ger cannot be attributed to contamination from host
RNA alone. Moreover, RNA from 15/40 cells grown
in vitro contains comparably large amount of /
transcript.
To analyze MHC class molecules the membrane
was first hybridized with a probe specific for the
classical MHC class I transcript (A12 c3 domain),
which corresponds to the antigen recognized by
mAb TB17 (Schum et al., 1993). The membrane was
then hybridized with an 3 CL4 probe that had
been shown to hybridize with at least 10 to 20
different nonclassical MHC class I-like sequences of
yet unknown function (Flajnik et al., 1991; Flajnik et
al., 1993). By using the A12 probe, two transcripts
of 2.4 and 1.4 kd were detected in normal thymus
and in if-2 and 15/40 tumor cells (either from in
vivo transfer or from in vitro culture). In contrast,
B3B7 and 15/0 yielded no signals. But after hybrid-
izing with the CL4 probe under stringent condi-
tions, two transcripts were detected in all RNA
samples (Fig. 4), including the 15/0 tumor and B3B7
cell line. The sizes of the transcripts identified by the
A12 and CL4 probes are similar.
Hybridization with a Xenopus myc-specific probe
detected a large amount of Myc mRNA, especially in
the B3B7 cell line and the 15/0 tumor, which we
estimate to contain more Myc RNA than do normal
thymocytes (Fig. 4) or the A6 kidney cell line (data
not shown). Two distinct copies of Xenopus c-myc
gene have been isolated, but their discrimination is
only possible by using oligonucleotide specific of the
5’ untranslated region (Principaud and Spohr, 1991;
Vriz et al., 1989). The elevated or deregulated
expression of c-myc oncogene has been reported for
a large number of tumor cells in higher vertebrates
and its involvement in neoplastic transformation
has been postulated (for a review, see DePinho et
al., 1991). A similar implication of c-myc is likely in
these Xenopus lymphoid tumors.
Discussion
We regularly examine our frogs for evidence of
tumors and found no lymphoid tumors in the first
20 years or so of its existence. Then, at the begin-
ning of 1992, the first Xenopus lymphoid tumor
MAR1 was discovered in our colony (Du Pasquier
and Robert, 1992), and 8 months later, three more
appeared. We are not yet sure of the factors respon-
sible for these neoplasms. It would not seem to be
genetics, for three different clonal lines of Xenopus
are involved (if, LG15, and LG15/40). Moreover,
infectious fungi or bacteria are definitively not in-
volved. The new tumors, like MAR1, can only be
propagated in isogenic or highly homozygous hosts;LYMPHOID TUMORS OF XENOPUS LAEVIS 303
FIGURE 4. Northern blot analysis of the various tumors and normal thymocytes (Thy) with Xenopus C, c-myc, and classical and
nonclassical MHC class probes. Cytoplasmic RNA (10/g) was electrophoresed in a 1% formaldehyde-agarose gel, transfered to a
nylon membrane and hybridized with 32p-labeled probes. The sizes of mRNAs were calibrated using RNA markers from BRL. The
integrity of each RNA sample was controlled by reprobing the membrane with a X. laevis Ef-l probe.
15/40 tumor cells can also grow in vitro. Such
criteria strongly support the interpretation that we
are dealing with real lymphoid tumors and not with
granulomas (Asfari and Thi6baud, 1988). Each tu-
mor seems to be the result of an independent
oncogenic event. That is, they appeared in animals
of different genetic background, they behave differ-
ently after transplantation, and they display distinct
phenotypes, as shown by flow cytometry and
Northern blotting. All attempts to demonstrate the
presence of a virus have been unsuccessful. Like the
B3B7 cell line, which was derived from the MAR1
tumor, all of the new tumors have mixed T-B
phenotypes (several surface markers of T cells, but
Ig RNA is transcribed). Aside from the possibility of
enabling us to learn more about neoplasm biology in
amphibians, these tumors provide a panel of new
experimental models to study lymphocyte differen-
tiation and the ontogeny of the immune system in
amphibians.
Growth Capacities of the Transplanted Tumor
Cells in Larval and Adult Histocompatible
Hosts
MAR1 and if-2 tumor cells grow only in histocom-
patible larval hosts, whereas 15/0 or 15/40 tumor
cells grow both in larvae and adults. The if-2 tumor
cells express clasical MHC class I chain in associ-
ation with ,82-microglobulin on the cell surface,
whereas MARl-derived B3B7 cells of the same
strain (if) do not. In contrast to mammals, which
express class I in the embryonic stages, the classical
MHC class molecules of Xenopus (present on the
membrance of almost all cells in the adult) are not
detected in young tadpoles and appear only during
metamorphosis (Flajnik et al., 1986; Flajnik and Du
Pasquier, 1988). In vivo transplantation into young
tadpoles (stages 55-56), or into tadpoles that have
been inhibited from metamorphosing, does not
modify class I expressing if-2 tumor cells as judged304 J. ROBERT et al.
by fluocytometry or immunoprecipitation. Never-
theless, the larval immune system does not seem to
be able to reject these class I bearing cells, although
there is no obvious reason why it should be tolerant
to them.
The fate of tumor cells in the adult does not seem
to depend on the expression of MHC class I mole-
cules on the cell surface, because both class I
/ if-2
and class I- MAR1 tumor cells do not grow, or
rarely grow, in adults older than 2 months after
fertilization. Several hypothesis can be advanced to
explain this peculiarity. The preferential growth in
tadpoles, independence of MHC class I expression,
might be due to a better capacity-of the adult
immune system to detect and kill tumor cells. The
rejection of MAR1 tumor in irradiated adults (with
exception of one case) as well as in thymectomized
allogenic toads (Du Pasquier and Robert, 1992)
suggests that additional, nonimmunological factors
are involved. A detailed analysis of tumor growth at
various developmental stages is in progress; we will
determine whether tumor rejection coincides with
the host acquiring full immunological maturity.
Other possible mechanisms of the developmen-
tal variation in tumor rejection should be consid-
ered: (1) absence of tumor-specific recognition by
the larval immune system, (2) developmental acti-
vation in the host of a resistance gene during
metamorphosis, and (3) upregulation of expression
by the tumor of a new polymorphic determinant
acting as a strong antigen recognizable only by the
adult TCR or Ig. The presence of other related
MHC class I transcripts found in the cytoplasm of
15/0 and B3B7 cell line should also be considered.
There exist at least 20 different genes encoding
class I-like sequences, most of which are not
MHCqinked (Flajnik et al., 1993). Their function
and their specific expression are as yet unknown,
but it is possible that at least one of these MHC
I-like proteins is involved in the developmentally
regulated tumor rejection. Within the ff family,
skin grafts are often accepted for more than 200
days, but these grafts are eventually rejected after
300 days; thus, this family is not isogenic at all
histocompatibility loci (Du Pasquier and Chardon-
nens, 1975). New family studies are necessary to
determine whether or not minor histocompatibility
antigens still segregating in our ff pool are respon-
sible for the rejection of tumor transplants by
adults. In any case, we do not understand why the
tumor cells should not be accepted for at least
some months. In addition to classical immunologi-
cal parameters, endocrine factors, homing prob-
lems, and NK cells could interfere with the growth
of tumor cells in the adult more than in the
tadpole. Following the fate of transplanted tumor
cells through metamorphosis and for a few months
thereafter might enable us to determine the period
of rejection more precisely and correlate it with,
for example, the histogenesis of the thymus that
takes place 1 month after metamorphosis.
In contrast to if-2 and the previously described
MAR1 tumor cells, 15/0 and 15/40 cells can grow
in adults of the LG15 genotype. The LG15/0
tumor developed in an animal that was genetically
identical to the other LG15 individuals (Kobel and
Du Pasquier, 1975). The LG15/40 subline devel-
oped from a small egg and has undergone some
genetic recombination; nevertheless; LG15/40 does
not express any gene that would not be expressed
in LG15 (Ibid). Thus, as expected, the 15/40 tu-
mor cells grow perfectly well in LG15 animals. A
more extensive genetic study of tumor transplanta-
tion in the case of the 15/0 and 15/40 tumors is
made possible by the existence of a family of
seven clone sibs of LG15 (LG 3, 5, 6, 7, 14, 17, 46;
Kobel and Du Pasquier, 1977) that offer various
patterns of segregation of MHC and other histo-
compatibility loci inherited from a single pair of
parents.
Expression of the Immunoglobulin # Messenger
Although the strong expression of fl Ig heavy-chain
messenger by the three new tumors, 15/0, 15/40,
and if-2, there is not trace of Ig protein chains.
Because specific transcripts of the expected size
(Schwager et al., 1988) are present, at least one Ig
havey-chain locus must have undergone somatic
rearrangement. Experiments are in progress to sub-
stantiate and extend this point. In the MAR1 cell
line, both Ig heavy-chain and two light-chain loci
have been rearranged (Du Pasquier and Robert,
1992; Du Pasquier et al. in preparation). Preliminary
investigation with 15/40 tumors cells using specific
VH probes indicates the presence of complete /
mRNA (data not shown) but does not exclude the
synthesis of an additional, truncated messenger as
described earlier. Because the translated product
might be rather unstable, it would be interesting to
submit 15/40 cells to short pulses of metabolic
labeling before immunoprecipitation. Anchored or
single-sided PCR with a C/ primer may also be
considered in order to isolate and sequence mRNAs
of different length (Troutt et al. 1992).LYMPHOID TUMORS OF XENOPUS LAEVIS 305
Despite the rearrangement of Ig genes in all
tumors, and the expression of Ig messengers in three
of them, none of the tumor seems to synthesize Ig
protein chains. Perhaps all these messengers are
simply out of frame. But another possibility would
be that Ig production is selected against, and
Ig-negative cells outgrow, the Ig-positive cells in
incipient tumors. There might also be some incom-
patibilities between the expression of the various
T-cell markers and the synthesis of Ig. In any case,
sequence analysis of corresponding Ig gene rear-
rangements that are in progress would clarify these
point.
Use of Tumor Cells as a Source of Proteins of
Immunological Interest
Large amounts of proteins of immunological interest
can be purified from tumor tissue and characterized
without contamination by other cell types. One such
protein is ,82 microglobulin, for which no specific
antibodies are available and for which the gene has
not been cloned and sequenced in Xenopus. Its
association with the class I chain at the surface of
if-2 cells means that anti-MHC I specific allosera can
be used to immunoprecipitate and isolate the mol-
ecule for peptide sequencing. The tumor offers a
better starting material than red cells, the lysate of
which are always rich in the globin 13 kd monomer
that interferes with ,82-m isolation.
Another protein of interest is the putative CD8
molecule recognized by mAb AM22. The presump-
tion of homology of this molecule to mammalian
CD8 is based on the similarity of apparent molecular
weight and tissue distribution; there are no protein
or DNA sequences. The high level of expression by
the various tumors of at least one CD8-1ike subunit
should enable us to immunoprecipitate enough ma-
terial to sequence.
The 15/40 tumor cells are now proliferating in
vitro, and new, cloned cell lines will soon be estab-
lished. The same strategy of successive passages
from in vivo transplantation to in vitro culture is
being followed with the two other tumor types.
MATERIAL AND METHODS
Toads
The Xenopus ff inbred family (Du Pasquier and
Chardonnens, 1975) is highly homozygous. As
these animals retain skin grafts for more than 200
days, they are considered to be histocompatible.
LG15 isogenic clones have been described in detail
elsewhere (Kobel and Du Pasquier, 1975). The
LG15/40 line arose from the development of a
small egg that did not undergo genomic duplication
and was therefore recombinant (Kobel and Du
Pasquier, 1977; Wilson et al., 1992). Development
was blocked before metamorphosis at stage 48
(Nieuwkoop and Faber, 1967) by adding 0.1%
potassium perchlorate (KC104) to the water (Busca-
glia, 1977).
Cell Culture
A cell line was derived from the LG15/40 tumor in
the same way as line B3B7 was derived from MAR1
(Du Pasquier and Robert, 1992) by 6 months of
repeated in vivo and in vitro passage. Culture media
and culture conditions have been described (Du
Pasquier and Robert, 1992).
Flow Cytometry
Samples of 105 cells stained with fluorescence-
labeled hybridoma supernatants were analyzed by
flow cytometry on a FACScan apparatus, as de-
scribed by Du Pasquier and Flajnik (1990).
Immunoprecipitation
Cell-surface iodination and lysis in NP-40 were
done as described (Kaufman et al., 1985; Flajnik and
Du Pasquier, 1988). A solid-phase immunoisolation
technique (SPIT) was used (Tamura et al., 1984;
Flajnik et al., 1988). A 96-well plate was coated
overnight at 4C with 100 1 of goat anti-mouse Ig
at 100 g/ml (Kierkegaard), washed and blocked
with 1% BSA in PBS, and incubated at room
temperature 2 x 2 hr with 100 1 of specific hybri-
doma supernatants. After washing several times,
radiolabeled cell-surface lysates (10s cpm/ml corre-
sponding to ca. 106 cells were incubated overnight
at 4C. After washing twice with cold 50 mM Tris
(pH 8), 500 mM NaC1, 1 mg/ml ovalbumin, and
twice with 50 mM Tris, 100 mM NaC1, the samples
were resuspended in Laemlli sample buffer with 5%
2-mercaptoethanol and separated on 10% SDS-
polyacrylamide gels. Cells labelled in vitro with
35S-methionine were immunoprecipitated with spe-
cific alloantisera, as described (Kaufman et al., 1985;
Flajnik and Du Pasquier, 1988).306 J. ROBERT et al.
Western Blot Analysis
Cell lysates were prepared with NP-40, as described
(Flajnik et al., 1991), separated on 10% SDS-
polyacrylamide gels, and electroblotted on immun-
lite membrane (Bio Rad). After incubation with
hybridoma supernatants, the membranes were as-
sayed by chemoluminescence (Bio Rad).
Northern Blot Analysis
Cytoplasmic RNA from a cell suspension of spleen
lymphocytes and cell lines was isolated by the
vanadyl-ribonuclease complex method (Berger,
1987), and liver total RNA was isolated by the guani-
dinium isothiocyanate procedure (Chomcyznski and
Sacchi, 1987). RNA (10/g/slot) was separated on
1% agarose-2.2 M formaldehyde gel according to a
standard protocol (Davis et al., 1986), transferred to
Hybond-N + membranes (Amersham), and fixed
with 50 mM NaOH. Prehybridization (6-16 hr) and
hybridization (24-48 hr) were performed in 50%
formamide at 45C with 32p-labeled Xenopus C/ or
VH probes (Schwager et al., 1988). MHC class I clas-
sical and nonclassical c3 probes were a kind gift of
M. Flajnik (Shum et al., submitted for publication;
Flajnik et al., 1991). The myc probe was kindly pro-
vided by E. Principaud (Principaud and Spohr,
1991). Filters were washed 2 x 30 min at 65C in
0.2 x SSC. 0.2% SDS. The sizes of mRNAs were
calibrated usingRNA markers (BRL). The integrity of
each RNA sample was controlled by reprobing the
membrane with a X. laevis elongation factor
lcffEf-lc) probe (Krieg et al., 1989)
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